Rapport Therapeutics (RAPP) News
NASDAQ: RAPPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.65+0.80 (+2.68%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
RAPP news summary
We found 1 recent headline mentioning Rapport Therapeutics (RAPP): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, RAPP is up 2.68% at $30.65. The most recent story, "Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.", was published by Nasdaq on Aug 31, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology